Printer Friendly
The Free Library
14,573,341 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Shionogi to Sell Shionogi Qualicaps Group to Carlyle Group.


Tokyo, Japan, Aug 23, 2005 - (JCNN JCNN Japan Corporate News Network ) - Shionogi to Sell Shionogi Qualicaps Group to Carlyle Group The of this article or section may be compromised by "weasel words".
You can help Wikipedia by removing weasel words.

The Carlyle Group is a Washington, D.C.
 

Shionogi announced on August 22 that it has decided to transfer all shares of the Shionogi Qualicaps Group to the Carlyle Group. In line with this decision, Shionogi and the Carlyle Group entered into a share transfer agreement on the same day.

The Shionogi Qualicaps Group consists of four companies: Shionogi Qualicaps Co., Ltd., Shionogi Europe B.V., Shionogi Qualicaps, S.A., and Shionogi Qualicaps, Inc. The group ranks second in the global market for pharmaceutical capsules.

Shionogi reached a conclusion that the group will most enhance its capability and competitiveness under the auspices aus·pi·ces 1  
n.
Plural of auspex.


auspices
Noun, pl

under the auspices of with the support and approval of [Latin auspicium augury from birds]

Noun
 of the Carlyle Group.

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Geographic Code:1USA
Date:Aug 24, 2005
Words:129
Previous Article:Matsushita Ecology System Develops Bacteriological Test System for Raw Milk.
Next Article:Suntory International, Blavod Extreme Spirits Establish Joint Venture Company in US.



Related Articles
QUARK SIGNS RESEARCH PACT WITH SHIONOGI.
Degussa AG, Dusseldorf, Germany, and Shionogi, Osaka, Japan, announced they will establish a joint venture in Japan for precipitated silica, silica...
Shionogi Launches New Quinolone Antibacterial "Avelox(R) Tablet 400mg" (Moxifloxacin Hydrochloride).
Shionogi, Purdue Pharma to Collaborate to Develop and Market New Analgesic Drug Compounds.
Shionogi, Galderma to Promote Acne Medicine Adapalene in Japan.
Shionogi, Nippon Kayaku Receive Approval for Cetrotide.
Shionogi, Response Biomedical to Conclude Sales Agreement for Rapid BNP Test.
Shionogi Verifies Effectiveness of S-2367, Its Investigational Agent for Obesity Management.
Shionogi Obtains Manufacturing, Marketing Approval for OXINORM Powder 0.5%.
Shionogi Launches Cancer Pain Analgesic OxiNorm Powder 0.5% in Japan.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles